1. Home
  2. AKR vs IRON Comparison

AKR vs IRON Comparison

Compare AKR & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

HOLD

Current Price

$21.08

Market Cap

2.6B

Sector

Real Estate

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$69.50

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKR
IRON
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
AKR
IRON
Price
$21.08
$69.50
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$22.25
$103.18
AVG Volume (30 Days)
1.0M
313.6K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
3.74%
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$410,757,000.00
N/A
Revenue This Year
$3.21
N/A
Revenue Next Year
$12.17
$283.52
P/E Ratio
$213.75
N/A
Revenue Growth
14.20
N/A
52 Week Low
$18.04
$40.00
52 Week High
$22.36
$99.50

Technical Indicators

Market Signals
Indicator
AKR
IRON
Relative Strength Index (RSI) 60.31 56.24
Support Level $19.61 $57.79
Resistance Level $21.18 $69.36
Average True Range (ATR) 0.40 2.57
MACD 0.19 0.64
Stochastic Oscillator 76.05 62.61

Price Performance

Historical Comparison
AKR
IRON

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: